BCG vaccine

E104005

The BCG vaccine is a widely used immunization that primarily protects against severe forms of tuberculosis, especially in young children.

All labels observed (4)

Label Occurrences
BCG 1
BCG vaccine canonical 1
BCG vaccine (with collaborators) 1

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf tuberculosis vaccine
vaccine
abbreviation BCG vaccine self-linksurface differs
surface form: BCG
alsoUsedFor treatment of non–muscle-invasive bladder cancer
boosterRecommendation no routine booster recommended by WHO
commonSideEffect local injection site reaction
permanent scar at injection site
small ulcer at injection site
contraindication severe immunodeficiency
symptomatic HIV infection in infants
derivedFrom Mycobacterium bovis
developedAt Pasteur Institute of Lille
developedBy Albert Calmette
Camille Guérin
developmentStartYear 1908
doesNotAffect interferon-gamma release assay results significantly
dosingSchedule single dose at birth in high-burden countries
effectOnTBTests can cause false-positive tuberculin skin test
efficacyRangePulmonaryTBAdults 0–80 percent in studies
efficacyVariation varies by geography and population
firstUsedInHumansYear 1921
formulation lyophilized powder for reconstitution
fullName BCG vaccine self-linksurface differs
surface form: Bacillus Calmette–Guérin vaccine
globalUse one of the most widely used vaccines worldwide
highEfficacyFor prevention of severe childhood TB forms
includedIn many national immunization programs
mechanismInBladderCancer stimulates local immune response in bladder
notRoutinelyRecommendedIn countries with low tuberculosis incidence
organismType live attenuated bacterium
primaryUse prevention of tuberculosis
protectsAgainst Mycobacterium tuberculosis infection
miliary tuberculosis
tuberculous meningitis
protectsBestAgainst severe forms of tuberculosis in children
recommendedBy World Health Organization
recommendedIn countries with high tuberculosis prevalence
researchArea non-specific immune effects
potential protection against other infections
routeOfAdministration intradermal injection
seriousAdverseEvent disseminated BCG infection in severely immunocompromised individuals
storageCondition refrigerated
strainType attenuated strain of Mycobacterium bovis
targetPopulation infants
newborns
young children
typicalInjectionSite upper arm
WHOModelListStatus included in WHO Model List of Essential Medicines

How these facts were elicited

Referenced by (4)

Full triples — surface form annotated when it differs from this entity's canonical label.

EPI usesVaccine BCG vaccine
subject surface form: Expanded Programme on Immunization
BCG vaccine fullName BCG vaccine self-linksurface differs
this entity surface form: Bacillus Calmette–Guérin vaccine
BCG vaccine abbreviation BCG vaccine self-linksurface differs
this entity surface form: BCG
Institut Pasteur developed BCG vaccine
this entity surface form: BCG vaccine (with collaborators)